Literature DB >> 16184345

[Do B cells play an important role in the pathogenesis of rheumatoid arthritis?].

C Berek1.   

Abstract

The role of B cells for the pathogenesis of rheumatoid arthritis (RA) has been debated for a long time. Here we show that chronic inflammation in the affected joints leads to the development of ectopic germinal centers. A micro-environment is established which supports B cell activation and differentiation. Plasma cells may develop which secrete autoantibodies of high affinity directly into the synovial tissue. Antigen/antibody complex formation, the activation of the complement cascade and the stimulation of macrophages may contribute to the destruction of joints. Furthermore, B cells are efficient antigen presenting cells. They seem to play a pivotal role in the activation of synovial T cells and the induction of cytokine secretion. The success of B cell depletion therapy by using the monoclonal antibody Rituximab further emphasized the importance of B cells in the pathogenesis of RA.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16184345     DOI: 10.1007/s00393-005-0779-4

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  29 in total

1.  Affinity maturation in ectopic germinal centers.

Authors:  B A de Boer; I Voigt; H J Kim; S A Camacho; M Lipp; R Förster; C Berek
Journal:  Curr Top Microbiol Immunol       Date:  2000       Impact factor: 4.291

Review 2.  Follicular dendritic cell-signaling molecules required for proliferation and differentiation of GC-B cells.

Authors:  Li Li; Yong Sung Choi
Journal:  Semin Immunol       Date:  2002-08       Impact factor: 11.130

Review 3.  Aberrant activation of B cells in patients with rheumatoid arthritis.

Authors:  Steffi Lindenau; Susann Scholze; Marcus Odendahl; Thomas Dörner; Andreas Radbruch; Gerd-Rüdinger Burmester; Claudia Berek
Journal:  Ann N Y Acad Sci       Date:  2003-04       Impact factor: 5.691

4.  Plasma cell survival is mediated by synergistic effects of cytokines and adhesion-dependent signals.

Authors:  Giuliana Cassese; Sergio Arce; Anja E Hauser; Katja Lehnert; Beate Moewes; Miro Mostarac; Gwendolin Muehlinghaus; Martin Szyska; Andreas Radbruch; Rudolf A Manz
Journal:  J Immunol       Date:  2003-08-15       Impact factor: 5.422

Review 5.  Reassessing the function of immune-complex retention by follicular dendritic cells.

Authors:  Ann M Haberman; Mark J Shlomchik
Journal:  Nat Rev Immunol       Date:  2003-09       Impact factor: 53.106

6.  Biological insights from clinical trials with anti-TNF therapy.

Authors:  M Feldmann; P Charles; P Taylor; R N Maini
Journal:  Springer Semin Immunopathol       Date:  1998

7.  Sustained improvement in rheumatoid arthritis following a protocol designed to deplete B lymphocytes.

Authors:  J C Edwards; G Cambridge
Journal:  Rheumatology (Oxford)       Date:  2001-02       Impact factor: 7.580

8.  Decrease in cellularity and expression of adhesion molecules by anti-tumor necrosis factor alpha monoclonal antibody treatment in patients with rheumatoid arthritis.

Authors:  P P Tak; P C Taylor; F C Breedveld; T J Smeets; M R Daha; P M Kluin; A E Meinders; R N Maini
Journal:  Arthritis Rheum       Date:  1996-07

9.  Individual germinal centres of myasthenia gravis human thymuses contain polyclonal activated B cells that express all the Vh and Vk families.

Authors:  V Guigou; D Emilie; S Berrih-Aknin; F Fumoux; M Fougereau; C Schiff
Journal:  Clin Exp Immunol       Date:  1991-02       Impact factor: 4.330

10.  Prevention of arthritis by interleukin 10-producing B cells.

Authors:  Claudia Mauri; David Gray; Naseem Mushtaq; Marco Londei
Journal:  J Exp Med       Date:  2003-02-17       Impact factor: 14.307

View more
  1 in total

1.  Deep immune phenotyping reveals similarities between aging, Down syndrome, and autoimmunity.

Authors:  Katharina Lambert; Keagan G Moo; Azlann Arnett; Gautam Goel; Alex Hu; Kaitlin J Flynn; Cate Speake; Alice E Wiedeman; Vivian H Gersuk; Peter S Linsley; Carla J Greenbaum; S Alice Long; Rebecca Partridge; Jane H Buckner; Bernard Khor
Journal:  Sci Transl Med       Date:  2022-01-12       Impact factor: 19.319

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.